{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:20Z","timestamp":1790959160813,"version":"4.1.0"},"reference-count":69,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J cachexia sarcopenia muscle"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer\u2010associated cachexia (CAC) is a wasting syndrome characterized by involuntary weight loss and anorexia. Clear definition and diagnostic criteria for CAC are lacking, which makes it difficult to estimate its prevalence, to interpret research and to compare studies. There is no standard treatment to manage CAC, but previous studies support the use of cannabinoids for cachexia in other chronic diseases including HIV and multiple sclerosis. However, only a few randomized controlled trials (RCTs) and one meta\u2010analysis of this intervention in cancer populations are available. Non\u2010randomized studies of interventions (NRSIs) are often excluded from reviews due to variable methodology and potential for biases. This review aimed to consider NRSIs alongside RCTs to provide a complete summary of the available evidence that clinical decision makers could use in future investigations. Literature searches were conducted using three databases for relevant RCTs or NRSIs according to Cochrane methodology. Abstract and full texts of retrieved manuscripts were selected and retrieved by two investigators based on the PRISMA\u2010A guidelines, and risk of bias and quality of evidence assessments were performed. Outcome data on weight, appetite, quality of life, performance status, adverse effects, and mortality were combined by narrative synthesis and meta\u2010analysis where possible. Ten studies were included, four of which were RCTs and six NRSIs matching the eligibility criteria. Very low\u2010quality evidence from meta\u2010analysis suggested no significant benefits of cannabinoids for appetite compared with control (standardized mean difference: \u22120.02; 95% confidence interval: \u22120.51, 0.46;\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00.93). Patient\u2010reported observations from NRSIs suggested improvements in appetite. Another meta\u2010analysis of moderate quality evidence showed that cannabinoids were significantly less efficient than active or inactive control on quality of life (standardized mean difference: \u22120.25; 95% confidence interval: \u22120.43, \u22120.07;\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00.007). The effectiveness of cannabinoids alone to improve outcomes of CAC remains unclear. Low\u2010quality evidence from both RCTs and NRSIs shows no significant benefits of cannabinoids for weight gain, appetite stimulation, and better quality of life, three important outcomes of cachexia. Higher quality research integrating cannabinoids into multi\u2010modal therapies may offer better opportunities for developing CAC\u2010specific treatments. This review also highlights that findings from non\u2010randomized studies of interventions (NRSIs) can provide evidence of the effects of an intervention and advocate for the feasibility of larger RCTs.\n                  <\/jats:p>","DOI":"10.1002\/jcsm.12861","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T01:13:25Z","timestamp":1639012405000},"page":"23-41","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta\u2010analysis"],"prefix":"10.1002","volume":"13","author":[{"given":"Lucile","family":"Simon","sequence":"first","affiliation":[{"name":"Division of Medicine University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia Z.","family":"Kalea","sequence":"additional","affiliation":[{"name":"Division of Medicine University College London  London UK"},{"name":"Institute of Cardiovascular Sciences University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Slee","sequence":"additional","affiliation":[{"name":"Division of Medicine University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12388"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2008.02.006"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/61.1.72"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665115002311"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12167"},{"key":"e_1_2_10_9_1","volume-title":"Cachexia. StatPearls [Internet]","author":"Rogers JB","year":"2020"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0800-6"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12402"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05259-1"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607108325076"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12307"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188359"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.4081\/ejtm.2019.7960"},{"key":"e_1_2_10_17_1","first-page":"1","article-title":"Medical cannabinoids for cancer cachexia: a systematic review and meta\u2010analysis","volume":"2019","author":"Wang J","year":"2019","journal-title":"Biomed Res Int"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2013.01.004"},{"key":"e_1_2_10_19_1","article-title":"Megestrol acetate for the treatment of anorexia\u2010cachexia syndrome","author":"Berenstein EG","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.09.007"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.1.152"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-6-199409150-00001"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.108"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90385-F"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.4\/nkogan"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.06.016"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00117-4"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12273"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1300\/J175v02n01_03"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000057152"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7256.255"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch14"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch24"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1847"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch15"},{"key":"e_1_2_10_38_1","first-page":"700","article-title":"Interpreting estimates of treatment effects: implications for managed care","volume":"33","author":"Faraone SV","year":"2008","journal-title":"Pharm Therapeut"},{"key":"e_1_2_10_39_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.2","author":"Deeks JJ","year":"2021"},{"key":"e_1_2_10_40_1","unstructured":"ChasenM.Safety and Efficacy of Inhaled Synthetic THC\/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia 2020. Available from:https:\/\/ClinicalTrials.gov\/show\/NCT04001010"},{"key":"e_1_2_10_41_1","unstructured":"ArrietaO.Nabilone Effect on the Attenuation of Anorexia Nutritional Status and Quality of Life in Lung Cancer Patients 2017. Available from:https:\/\/ClinicalTrials.gov\/show\/NCT02802540"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq727"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.567"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4154-9"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419881498"},{"key":"e_1_2_10_46_1","first-page":"S81","article-title":"Medical cannabis improves appetite and stabilizes weight in cancer patients","volume":"27","author":"Kasvis P","year":"2019","journal-title":"Support Care Cancer"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.21037\/apm.2018.08.04"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/082585979401000105"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.11.007"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.10.370"},{"key":"e_1_2_10_52_1","volume-title":"The Uniscale Assessment of Quality of Life: Applications to Oncology","author":"Ballatori E","year":"2010"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016670403148"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00038-9"},{"key":"e_1_2_10_55_1","first-page":"195","article-title":"Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?\u2010\u2010a pilot study","volume":"11","author":"Wilson MM","year":"2007","journal-title":"J Nutr Health Aging"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018802816"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802250"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540260902782810"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr200"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.12.030"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003489415612801"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422506"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.23.2962"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/510392"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.04.006"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.34_suppl.228"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-003-0486-0"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.10.004"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0756-3"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12501"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcsm.12861","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcsm.12861","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcsm.12861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T19:58:05Z","timestamp":1692475085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.12861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1002\/jcsm.12861"],"URL":"https:\/\/doi.org\/10.1002\/jcsm.12861","archive":["Portico"],"relation":{},"ISSN":["2190-5991","2190-6009"],"issn-type":[{"value":"2190-5991","type":"print"},{"value":"2190-6009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"assertion":[{"value":"2021-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}